Caprylidene

Caprylic triglyceride
Systematic (IUPAC) name
[2-octanoyloxy-1-(octanoyloxymethyl)ethyl] octanoate
Clinical data
Pregnancy cat.  ?
Legal status -only (US)
Routes Oral
Identifiers
CAS number 538-23-8
ATC code None
PubChem CID 10850
ChemSpider 10393 Y
KEGG D01587 Y
Synonyms Glycerol trioctanoate; Tricaprylin
Chemical data
Formula C27H50O6 
Mol. mass 470.68 g · mol−1
SMILES eMolecules & PubChem
 Y(what is this?)  (verify)

Caprylidene (trade name Axona) is a medical food that was approved in March 2009 by the U.S. Food and Drug Administration for the "clinical dietary management of the metabolic processes associated with mild to moderate Alzheimer’s disease".[1] Glucose metabolism by the brain is impaired in Alzheimer's disease, and it is proposed that ketone bodies may provide an alternative energy source. Caprylidene is a powdered form of caprylic triglyceride, a medium chain triglyceride (MCT) in which three molecules of caprylic acid are esterified with glycerol.[2]

Contents

See also

References

  1. ^ FDA-Approved Drugs 2009: Axona (caprylidene) CenterWatch. Cited 30 November 2009.
  2. ^ Axona Drugs.com. Cited 30 November 2009.

Further reading

External links